Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
The average of price targets set by Wall Street analysts indicates a potential upside of 35.6% in Inogen (INGN). While the effectiveness of this highly sought-after metric is questionable, the positiv
Teleflex, Integer Holdings and Inogen are defying tariff and supply chain headwinds with genAI-driven momentum within the Medical Instruments industry.
The mean of analysts' price targets for Inogen (INGN) points to a 49.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Inogen, Inc. (NASDAQ:INGN ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Kevin R. M. Smith - President, CEO & Director Lorna Williams - Corporate Participant Michael
INGN stock rises as Q2 loss narrows and revenue climbs 4% year over year, driven by strong B2B demand despite DTC and rental declines.
Inogen (INGN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.24 per share a year ago.
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025.
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy.

Inogen initiated with a Buy at B. Riley

08:25pm, Sunday, 15'th Jun 2025
B. Riley initiated coverage of Inogen with a Buy rating and $14 price target.
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
Broker upgrades boost URBN, INGN and SWX, with earnings growth and strong Zacks Ranks signaling potential upside despite market volatility.
Needham analyst Mike Matson upgraded Inogen, Inc INGN from Hold to Buy, with a price forecast of $12.

What Makes Inogen (INGN) a New Buy Stock

01:01pm, Friday, 16'th May 2025
Inogen (INGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE